LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency
Authors:
- David M. KallenbergDKDavid M. Kallenberg
- Rene JackstadtRJRene Jackstadt
- Markella AlatsatianosMAMarkella Alatsatianos
- Julia OhmeJOJulia Ohme
- Carlotta CamilliCCCarlotta Camilli
- Camilla PilottiCPCamilla Pilotti
- Athina DritsoulaADAthina Dritsoula
- Chantelle E. BowersCBChantelle E. Bowers
- Laura DowsettLDLaura Dowsett
- Jestin GeorgeJGJestin George
Preprint
Abstract
Vascular dysfunction contributes to the pro-oncogenic tumor microenvironment and impedes the delivery of therapeutics. Normalizing of the tumor vasculature has therefore become a potential therapeutic objective. We previously reported that the secreted glycoprotein, leucine-rich α-2-glycoprotein 1 (LRG1), contributes to the formation of pathogenic neovascularization. Here we show that in mouse models of cancer, Lrg1 is induced in tumor endothelial cells. We demonstrate that the expression of LRG1 impacts on tumor progression as Lrg1 deletion or treatment with a LRG1 function-blocking antibody inhibited tumor growth and improved survival. Inhibition of LRG1 increased endothelial cell pericyte coverage and improved vascular function resulting in significantly enhanced efficacy of cisplatin chemotherapy, adoptive T-cell therapy and immune checkpoint inhibition (anti-PD1) therapy. With immunotherapy, LRG1 inhibition led to a significant shift in the tumor microenvironment from being predominantly immune silent (cold) to immune active (hot). LRG1 therefore drives vascular abnormalization and its inhibition represents a novel and effective means of improving the efficacy of cancer therapeutics.Keywords
All Related Versions
- Published version: Med, 2 (11), 1231.
This publication has 62 references indexed in Scilit:
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyProceedings of the National Academy of Sciences, 2012
- Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cellsCancer Letters, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of CancerCancer Research, 2010
- Up-regulation of the expression of leucine-rich α2-glycoprotein in hepatocytes by the mediators of acute-phase responseBiochemical and Biophysical Research Communications, 2009
- KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endotheliumBlood, 2006
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationCancer Cell, 2004
- Endothelial-pericyte interactions in angiogenesisCell and tissue research, 2003
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971